Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation

International Journal of Pharmaceutics

Volumn 370, Issue 1-2, 2009, Pages 121-128

  Wenzel, Jane ^b   Zeisig, Reiner ^c   Fichtner, Iduna ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Experimental Pharmacology and Oncology GmbH   (Germany)

Author keywords

Breast cancer; Complex formation; Dipyridamole; Liposomes; Metastasis; Platelet aggregation

Indexed keywords

DIPYRIDAMOLE; LIPID; LIPOSOME; PERIFOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER MODEL; CELL ADHESION; CELL ENCAPSULATION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LIPID VESICLE; LUNG METASTASIS; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; BREAST NEOPLASMS; CELL LINE, TUMOR; DIPYRIDAMOLE; DRUG COMBINATIONS; FEMALE; HUMANS; LIPOSOMES; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC CELLS, CIRCULATING; PHOSPHORYLCHOLINE; PLATELET AGGREGATION INHIBITORS;

EID: 61349164810     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.11.023     Document Type: Article

References (44)

1. Al-Jamal W.T., and Kostarelos K. Construction of nanoscale multicompartment liposomes for combinatory drug delivery. Int. J. Pharm. 331 (2007) 182-185
2. Amirkhosravi A., Mousa S.A., Amaya M., Blaydes S., Desai H., Meyer T., and Francis J.L. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb. Haemost. 90 (2003) 549-554
3. Amirkhosravi M., and Francis J.L. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation. Thromb. Haemost. 73 (1995) 59-65
4. Anderson P. Liposomal muramyl tripeptide phosphatidyl ethanolamine, ifosfamide-containing chemotherapy in osteosarcoma. Future Oncol. 2 (2006) 333-343
5. Asai T., and Oku N. Liposomalized oligopeptides in cancer therapy. Methods Enzymol. 391 (2005) 163-176
6. Bloemen P.G., Henricks P.A., van Bloois L., van den Tweel M.C., Bloem A.C., Nijkamp F.P., Crommelin D.J., and Storm G. Adhesion molecules, a new target for immunoliposome-mediated drug delivery. FEBS Lett. 357 (1995) 140-144
7. Bobek V., and Kovarik J. Antitumor and antimetastatic effect of warfarin and heparins. Biomed. Pharmacother. 58 (2004) 213-219
8. Borsig L., Wong R., Feramisco J., Nadeau D.R., Varki N.M., and Varki A. Heparin and cancer revisited, mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3352-3357
9. Borsig L., Wong R., Hynes R.O., Varki N.M., and Varki A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 2193-2198
10. Crissman J.D., Hatfield J.S., Menter D.G., Sloane B., and Honn K.V. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res. 48 (1988) 4065-4072
11. Derksen J.T., Morselt H.W., and Scherphof G.L. Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim. Biophys. Acta 971 (1988) 127-136
12. Fidler I.J. Therapy of disseminated melanoma by liposome-activated macrophages. World J. Surg. 16 (1992) 270-276
13. Fidler I.J. Antivascular therapy of cancer metastasis. J. Surg. Oncol. 94 (2006) 178-180
14. Gao D., Nolan D.J., Mellick A.S., Bambino K., McDonnell K., and Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319 (2008) 195-198
15. Gosk S., Gottstein C., and Bendas G. Targeting of immunoliposomes to endothelial cells expressing VCAM, a future strategy in cancer therapy. Int. J. Clin. Pharmacol. Ther. 43 (2005) 581-582
16. Hejna M., Raderer M., and Zielinski C.C. Inhibition of metastases by anticoagulants. J. Natl. Cancer Inst. 91 (1999) 22-36
17. Ichikawa K., Hikita T., Maeda N., Yonezawa S., Takeuchi Y., Asai T., Namba Y., and Oku N. Antiangiogenic photodynamic therapy PDT by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochim. Biophys. Acta 1669 (2005) 69-74
18. Im J.H., Fu W., Wang H., Bhatia S.K., Hammer D.A., Kowalska M.A., and Muschel R.J. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 64 (2004) 8613-8619
19. Ji C., Na W., Fei X., Sheng-Jun C., and Jia-Bi Z. Characterization, lung targeting profile and therapeutic efficiency of dipyridamole liposomes. J. Drug Target. 14 (2006) 717-724
20. Keil C., Zeisig R., and Fichtner I. Effect of surface modified liposomes on the aggregation of platelets and tumor cells. Thromb. Haemost. 94 (2005) 404-411
21. Kessner S., Krause A., Rothe U., and Bendas G. Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells. Biochim. Biophys. Acta 1514 (2001) 177-190
22. Kim S.I., Kim K.S., Kim H.S., Kim D.S., Jang Y., Chung K.H., and Park Y.S. Inhibitory effect of the salmosin gene transferred by cationic liposomes on the progression of B16BL6 tumors. Cancer Res. 63 (2003) 6458-6462
23. Kragh M., and Loechel F. Non-anti-coagulant heparins, a promising approach for prevention of tumor metastasis review. Int. J. Oncol. 27 (2005) 1159-1167
24. Kwak E.L., Clark J.W., and Chabner B. Targeted agents, the rules of combination. Clin. Cancer Res. 13 (2007) 5232-5237
25. Maeda N., Miyazawa S., Shimizu K., Asai T., Yonezawa S., Kitazawa S., Namba Y., Tsukada H., and Oku N. Enhancement of anticancer activity in antineovascular therapy is based on the intratumoral distribution of the active targeting carrier for anticancer drugs. Biol. Pharm. Bull. 29 (2006) 1936-1940
26. Mancuso A., and Sternberg C.N. New treatment approaches in metastatic renal cell carcinoma. Curr. Opin. Urol. 16 (2006) 337-341
27. Mastrobattista E., Storm G., van Bloois L., Reszka R., Bloemen P.G., Crommelin D.J., and Henricks P.A. Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 ICAM-1 on bronchial epithelial cells. Biochim. Biophys. Acta 1419 (1999) 353-363
28. Mayer L.D., Harasym T.O., Tardi P.G., Harasym N.L., Shew C.R., Johnstone S.A., Ramsay E.C., Bally M.B., and Janoff A.S. Ratiometric dosing of anticancer drug combinations, controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice. Mol. Cancer Ther. 5 (2006) 1854-1863
29. Miyake K., Yamamoto S., and Iijima S. Blocking adhesion of cancer cells to endothelial cell types by S. agalactiae type-specific polysaccharides. Cytotechnology 22 (1996) 205-209
30. Naundorf H., Rewasowa E.C., Fichtner I., Büttner B., Becker M., and Görlich M. Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives. Breast Cancer Res. Treat. 23 (1992) 87-95
31. Nierodzik M.L., Plotkin A., Kajumo F., and Karpatkin S. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J. Clin. Invest. 87 (1991) 229-236
32. Raffaghello L., Pagnan G., Pastorino F., Cosimo E., Brignole C., Marimpietri D., Bogenmann E., Ponzoni M., and Montaldo P.G. Immunoliposomal fenretinide, a novel antitumoral drug for human neuroblastoma. Cancer Lett. 197 (2003) 151-155
33. Rivera E. Current status of liposomal anthracycline therapy in metastatic breast cancer. Clin. Breast Cancer 4 Suppl. 2 (2003) S76-S83
34. Rivey M.P., Alexander M.R., and Taylor J.W. Dipyridamole, a critical evaluation. Drug Intell. Clin. Pharm. 18 (1984) 869-880
35. Saiki I., Koike C., Obata A., Fujii H., Murata J., Kiso M., Hasegawa A., Komazawa H., Tsukada H., Azuma I., Okada S., and Oku N. Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation. Int. J. Cancer 65 (1996) 833-839
36. Sindelar W.F., Tralka T.S., and Ketcham A.S. Electron microscopic observations on formation of pulmonary metastases. J. Surg. Res. 18 (1975) 137-161
37. Stahn R., Grittner C., Zeisig R., Karsten U., Felix S.B., and Wenzel K. Sialyl Lewis x-liposomes as vehicles for site-directed, E-selectin-mediated drug transfer into activated endothelial cells. Cell Mol. Life Sci. 58 (2001) 141-147
38. Stekar J., Hilgard P., Voegeli R., Maurer H.R., Engel J., Kutscher B., Nossner G., and Schumacher W. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133. Cancer Chemother. Pharmacol. 32 (1993) 437-444
39. Trousseau A. Phlegmasia Alba Dolens, 3 (1865), The New Sydenham Society, London pp. 94-96
40. Wahrenbrock M., Borsig L., Le D., Varki N., and Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J. Clin. Invest. 112 (2003) 853-862
41. Zeisig R., Arndt D., Stahn R., and Fichtner I. Physical properties and pharmacological activity in vitro and in vivo of optimised liposomes prepared from a new cancerostatic alkylphospholipid. Biochim. Biophys. Acta 1414 (1998) 238-248
42. Zeisig R., Koklic T., Wiesner B., Fichtner I., and Sentjurc M. Increase in fluidity in the membrane of MT3 breast cancer cells correlates with enhanced cell adhesion in vitro and increased lung metastasis in NOD/SCID mice. Arch. Biochem. Biophys. 459 (2007) 98-106
43. Zeisig R., Müller K., Maurer N., Arndt D., and Fahr A. The composition-dependent presence of free micellar alkylphospholipid in liposomal formulations of octadecyl-1,1-dimethyl-piperidino-4-yl-phosphate affects its cytotoxic activity in vitro. J. Membr. Biol. 182 (2001) 61-69
44. Zeisig R., Stahn R., Wenzel K., Behrens D., and Fichtner I. Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro. Biochim. Biophys. Acta 1660 (2004) 31-40